
Analysis · Business & Industry
Why Can Essential Medicines Remain in Short Supply Even When Manufacturers Have Production Capacity?
ORV-110 · ORV-BBI-011 · BBI-011
Coming SoonNot available for purchase or download
About this publication
Pharmaceutical manufacturing capacity does not always translate into medicines that can be released and supplied to the market.
Using documented manufacturing-quality developments, industry shortage evidence, and US FDA regulatory information, this analysis examines how production capacity, quality testing, batch release requirements, and pharmaceutical market conditions can affect the availability of essential medicines, particularly sterile injectable products.
- Publication
- Analysis
- Primary domain
- Business & Industry
- Producer
- ORVESTRA
- Department
- Business Architecture
- Rights
- P’Toh
- Framework
- DGCP™
- License
- DGCP | MMFARM-POL-2025
CID: bafkreihbq3zdexcfvsjkyoylvjgeiphdeopt6576lncmm72mijkswhwvu4
← Back to Knowledge Library